ICM
FLGT icon

Invenomic Capital Management’s Fulgent Genetics FLGT Stock Holding History

Invenomic Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Sell
498,287
-112,031
-18% -$1.9M 0.61% 58
2026
Q1 		$9.7M Buy
+610,318
New +$13.2M 0.45% 67
2025
Q3 		– Sell
-31,125
Closed -$619K – 154
2025
Q2 		$619K Sell
31,125
-205,047
-87% -$4M 0.04% 143
2025
Q1 		$3.99M Sell
236,172
-22,838
-9% -$389K 0.2% 126
2024
Q4 		$4.78M Buy
259,010
+9,263
+4% +$181K 0.23% 112
2024
Q3 		$5.43M Buy
249,747
+124,185
+99% +$2.78M 0.3% 94
2024
Q2 		$2.46M Buy
+125,562
New +$2.62M 0.12% 139

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invenomic Capital Management's FLGT Position: Q2 2026 in Review

Invenomic Capital Management reduced its Fulgent Genetics (FLGT) stake by 18% in Q2 2026, selling an estimated $1.9M and leaving 498,287 shares worth $10.2M. The position accounts for 0.61% of the portfolio, ranked #58.

Invenomic Capital Management first reported a position in FLGT in Q2 2024 and has held it in 7 quarters since. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Invenomic Capital Management held 498,287 shares of Fulgent Genetics worth $10.2M as of Q2 2026.
  • Invenomic Capital Management sold 112,031 Fulgent Genetics shares in Q2 2026, an estimated $1.9M.
  • Fulgent Genetics made up 0.61% of Invenomic Capital Management's portfolio in Q2 2026, its #58 holding.
  • Invenomic Capital Management first reported a position in Fulgent Genetics in Q2 2024 and has held it in 7 quarters since.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.